Active Government Funding Opportunities

Support high-impact investigator-initiated research addressing ovarian cancer through basic laboratory to translational studies. Projects must demonstrate strong scientific rationale with preliminary data and potential to advance patient care.

Support innovative, high-risk pancreatic cancer research ideas with potential for major breakthroughs. This award funds early-stage projects addressing key research priorities, including mentorship pathways for early-career investigators launching careers in pancreatic cancer science.

DoD funds breakthrough breast cancer research advancing toward clinical trials, requiring multidisciplinary teams with consumer advocates. This Level 4 award targets high-impact discoveries ready for human testing and clinical application.

Support early-career clinical trialists developing new ovarian cancer treatments through intensive mentoring, networking, and conducting translational research and early-phase clinical trials.

Support early-career ovarian cancer researchers through an intensive virtual academy offering mentoring, networking, and collaboration. The program develops productive scientists while advancing innovative ovarian cancer research in a structured peer-learning environment.

This award funds partnerships between clinicians and scientists to accelerate pancreatic cancer research from promising early-stage ideas toward clinical applications, including pilot trials and correlative studies.

Accelerate drug discovery and therapeutic development for hearing restoration following military-relevant auditory injury. This program supports preclinical and clinical research to restore hearing function in service members.

This Army Medical Research Acquisition Activity award supports mentored clinical research in vision-related medical challenges. It aims to develop clinical solutions and advance vision care capabilities through structured mentorship and research training.

Supports investigator-led spinal cord injury research across basic to translational science phases. Aims to advance SCI patient care, treatment outcomes, and quality of life through competitive grants.

The Army seeks clinical trial research to advance vision capabilities and treatments. This opportunity supports innovative medical studies addressing soldier visual performance and eye health.

The Army seeks research ideas to advance understanding and countermeasures for tick-borne diseases affecting military readiness. This program supports early-stage scientific investigations to develop novel prevention, diagnosis, or treatment solutions.

This DoD funding supports clinical trials testing new spinal cord injury treatments with potential to significantly improve patient outcomes. The program welcomes early-career researchers and requires community partnership to ensure research relevance.

Army seeks investigator-initiated research proposals addressing vision science and ocular performance challenges. Support ranges from basic science through applied research to advance soldier visual capabilities and medical treatments.

The Army seeks translational research advancing vision science and optical technologies for military applications. This opportunity funds development of novel vision-related capabilities to bridge fundamental research and field-deployable solutions.

This DoD funding accelerates spinal cord injury research from promising ideas to clinical applications through translational research. It supports early-career partnerships and requires community engagement to ensure real-world relevance.

Develop novel therapeutics and diagnostic tools to prevent, treat, or detect tick-borne diseases like Lyme disease. This program funds R&D to address a significant public health threat through innovative medical countermeasures.

This DoD funding supports clinical translation research to move spinal cord injury treatments from preliminary studies into larger clinical trials. It prioritizes removing barriers to clinical success and identifying effective diagnosis, treatment, and rehabilitation options.

Mature cancer research with near-term clinical impact for military health systems. Supports studies including clinical trials addressing congressionally directed priorities in oncology.

DoD seeks innovative, high-risk cancer research concepts to advance treatment options and patient outcomes for Service Members and military beneficiaries. Preliminary data not required; creative thinking and untested ideas addressing unmet clinical needs are prioritized.

Accelerate cancer treatment breakthroughs through clinical trials testing new drugs, devices, and emerging therapies. This award funds rapid-cycle trials from proof-of-concept to phase III, addressing the urgent need to translate promising cancer interventions into patient care.

Develop and test broadly applicable clinical technologies addressing urgent military health needs through translational research and early-phase clinical trials. Multi-PI teams will advance platform products that benefit Service Members, Veterans, and their families.

DoD seeks clinical trial research to advance treatment and management of military-relevant diseases. This peer-reviewed program funds trials from early-phase (Phase 0/1) through large-scale Phase 3 studies, with optional planning support for regulatory preparation.

NSF seeks fundamental research advancing knowledge of STEM education across learning environments, broadening participation, and workforce development. Projects should generate foundational insights with potential long-term impact on educational practice across all learner groups and ages.

The Army seeks innovative melanoma research proposals to advance understanding of this deadly cancer and improve prevention, detection, and treatment strategies. This program funds early-stage ideas with potential to transform melanoma care and soldier health outcomes.

Support innovative research into rare melanoma subtypes to advance understanding of disease mechanisms and develop targeted treatment strategies. This Army-sponsored program funds basic and translational research addressing an underexplored cancer area with significant clinical impact.